Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2,512.43%-126.7K | 167.13%30.39K | -71.23%-208.61K | -266.34%-253.26K | -154.31%-91.42K | 104.43%5.25K | -220.53%-45.27K | -287.32%-121.83K | -57.11%152.25K | 360.63%168.33K |
| Net income from continuing operations | -457.53%-167.73K | -126.10%-51.11K | -5,270.99%-297.13K | 117.92%23.95K | 22.19%-224.52K | 490.11%46.92K | 105.55%195.81K | -91.98%5.75K | -453.46%-133.65K | -541.99%-288.55K |
| Operating gains losses | 91.93%-5.81K | 95.63%65.81K | 1,328.73%34.17K | -92.26%3.91K | 29.86%45K | -799.86%-71.94K | 9.23%33.64K | 59.50%-2.78K | -77.87%50.58K | 12.66%34.65K |
| Depreciation and amortization | -19.77%18.46K | -8.89%20.56K | -1.46%22.24K | 4.61%91.92K | 3.54%23.78K | 2.13%23.01K | 4.64%22.56K | 8.45%22.57K | -6.06%87.87K | -5.61%22.97K |
| Remuneration paid in stock | ---- | ---- | ---- | -67.58%33.93K | ---- | ---- | ---- | ---- | 709.36%104.67K | ---- |
| Other non cashItems | 32.75%904 | 128.46%1.12K | 58.83%1.39K | -49.62%3.61K | 26.38%1.56K | -57.86%681 | -75.45%492 | -62.14%872 | 24.87%7.16K | -52.97%1.24K |
| Change In working capital | 114.71%28.44K | 98.35%-4.9K | 121.78%32.1K | -1,056.50%-400.79K | -89.66%30.45K | 110.85%13.25K | -169.77%-297.12K | -619.41%-147.36K | -1.64%41.9K | 436.32%294.6K |
| -Change in receivables | 25.22%80.54K | 165.47%103.59K | 58.05%-65.24K | -58.20%-287.87K | -149.66%-42.13K | 143.94%64.31K | -1,047.11%-158.21K | -47.14%-155.52K | -688.69%-181.96K | 177.52%84.85K |
| -Change in prepaid assets | ---- | ---- | -92.05%293 | -138.42%-4.92K | ---- | ---- | ---- | 487.70%3.69K | -228.20%-2.06K | ---- |
| -Change in payables and accrued expense | -2.01%-52.1K | 21.90%-108.49K | 2,070.17%97.05K | -147.81%-108.01K | -63.41%77.5K | -310.21%-51.07K | -44.18%-138.91K | -94.81%4.47K | 2,140.64%225.92K | 945.71%211.81K |
| Interest paid (cash flow from operating activities) | -32.75%-904 | -128.46%-1.12K | -58.83%-1.39K | 49.62%-3.61K | -26.38%-1.56K | 57.86%-681 | 75.45%-492 | 62.14%-872 | -24.87%-7.16K | 52.97%-1.24K |
| Tax refund paid | 99.03%-58 | 115.03%23 | ---- | -799.10%-6.18K | -1,240.00%-57 | -767.04%-5.97K | -304.00%-153 | --0 | -43.04%884 | 107.69%5 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2,512.43%-126.7K | 167.13%30.39K | -71.23%-208.61K | -266.34%-253.26K | -154.31%-91.42K | 104.43%5.25K | -220.53%-45.27K | -287.32%-121.83K | -57.11%152.25K | 360.63%168.33K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -888.57%-1.04K | 71.85%-1.59K | 0 | 82.67%-10.73K | 66.82%-1.81K | 99.65%-105 | -70.11%-5.66K | 86.38%-3.16K | -2.78%-61.92K | 51.86%-5.47K |
| Net PPE purchase and sale | -888.57%-1.04K | 71.85%-1.59K | --0 | 82.67%-10.73K | 66.82%-1.81K | 99.65%-105 | -70.11%-5.66K | 86.38%-3.16K | -2.78%-61.92K | 51.86%-5.47K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -888.57%-1.04K | 71.85%-1.59K | --0 | 82.67%-10.73K | 66.82%-1.81K | 99.65%-105 | -70.11%-5.66K | 86.38%-3.16K | -2.78%-61.92K | 51.86%-5.47K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 242.18%76.82K | -107.15%-9.06K | -16.05%75.97K | 22,849.78%207.93K | 239.16%44.78K | -222.25%-54.03K | 492.50%126.68K | 363.74%90.5K | 99.72%-914 | -537.86%-32.18K |
| Net issuance payments of debt | -5.29%-11.75K | 5.28%-11.71K | 1.83%-11.99K | -1.47%-47.5K | 2.39%-11.77K | 5.93%-11.16K | -5.52%-12.36K | -9.23%-12.22K | 35.05%-46.82K | 37.23%-12.06K |
| Net other financing activities | 306.57%88.56K | -98.09%2.66K | -14.36%87.96K | 456.48%255.44K | 381.05%56.55K | -176.48%-42.87K | 320.12%139.05K | 544.08%102.71K | 117.68%45.9K | -242.04%-20.12K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 242.18%76.82K | -107.15%-9.06K | -16.05%75.97K | 22,849.78%207.93K | 239.16%44.78K | -222.25%-54.03K | 492.50%126.68K | 363.74%90.5K | 99.72%-914 | -537.86%-32.18K |
| Net cash flow | ||||||||||
| Beginning cash position | -61.73%111.3K | -62.30%82.61K | -19.98%191.9K | 25.48%239.82K | 108.76%240.6K | 30.21%290.83K | 27.87%219.1K | 25.48%239.82K | 3.91%191.13K | -50.14%115.25K |
| Current changes in cash | -4.17%-50.92K | -73.95%19.74K | -284.63%-132.64K | -162.69%-56.05K | -137.07%-48.45K | 53.20%-48.88K | 36.23%75.76K | -555.62%-34.49K | 342.32%89.42K | 261.36%130.68K |
| Effect of exchange rate changes | 283.30%2.48K | 322.08%8.95K | 69.68%23.35K | 119.97%8.13K | 95.99%-245 | 63.03%-1.35K | -11.76%-4.03K | 150.32%13.76K | -192.37%-40.72K | -114.91%-6.11K |
| End cash Position | -73.87%62.86K | -61.73%111.3K | -62.30%82.61K | -19.98%191.9K | -19.98%191.9K | 108.76%240.6K | 30.21%290.83K | 27.87%219.1K | 25.48%239.82K | 25.48%239.82K |
| Free cash from | -2,581.81%-127.74K | 156.55%28.79K | -66.91%-208.61K | -392.23%-263.99K | -157.24%-93.23K | 103.46%5.15K | -248.76%-50.92K | -398.42%-124.98K | -69.35%90.33K | 314.45%162.86K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.